Back to Driehaus Capital Management LLC Driehaus Capital Management LLC

APGEAPGE

13 quarters

Position history for Driehaus Capital Management LLCDriehaus Capital Management LLC's holdings in APOGEE THERAPEUTICS INC

As of its Q2 2026 13F, Driehaus Capital Management held 1,740,101 shares of APGE (Apogee Therapeutics), worth $231M. Driehaus Capital Management listed APGE in 12 quarterly 13F filings through Q2 2026. APGE was 1.3% of Driehaus Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$28.5M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q2
Decreased
1.7M
-9.4%
$231M1.3%$132.73
0
2026-Q1
Decreased
1.9M
-12.0%
$161.7M1.2%—
0
2025-Q4
Increased
2.2M
+1.2%
$164.8M1.1%—
48
2025-Q3
Decreased
2.2M
-6.6%
$85.8M0.6%—
0
2025-Q2
Decreased
2.3M
-1.2%
$100.4M0.8%—
0
2025-Q1
Decreased
2.3M
-10.2%
$87.4M0.8%—
0
2024-Q4
Increased
2.6M
+2.8%
$118M1.0%—
44
2024-Q3
Increased
2.5M
+19.6%
$148.8M1.3%$57.99
57
2024-Q2
Increased
2.1M
+2.6%
$83.3M0.8%$39.35
43
2024-Q1
Increased
2.1M
+55.3%
$137.1M1.4%$66.45
67
2023-Q4
Decreased
1.3M
-0.8%
$37.1M0.4%$27.94
0
2023-Q3
New
1.3M
—
$28.5M0.4%$21.30
48

Optional analytics helps us improve. How it’s used